Objective: To compare the effectiveness of a novel model of care (“Stepping Up”) with usual primary care in normalising insulin initiation for type 2 diabetes, leading to improved glycated haemoglobin (HbA1c) levels. Design: Cluster randomised controlled trial. Setting: Primary care practices in Victoria, Australia, with a practice nurse and at least one consenting eligible patient (HbA1c ≥7.5% with maximal oral treatment). Participants: 266 patients with type 2 diabetes and 74 practices (mean cluster size 4 (range 1-8) patients), followed up for 12 months. Intervention: The Stepping Up model of care intervention involved theory based change in practice systems and reorientation of the roles of health professionals in the primar...
Type 2 diabetes (T2D) brings significant human and healthcare costs. Its progressive nature means ac...
Objective To evaluate the effects of insulin 30/70 twice daily or bedtime isophane (NPH) insulin plu...
Background. Most people with type 2 diabetes (T2D) have glycaemic levels outside of target. Insulin ...
Objective: To compare the effectiveness of a novel model of care (“Stepping Up”) with usual primary ...
Objective To compare the effectiveness of a novel model of care (“Stepping Up”) with usual primary c...
Objective To compare the effectiveness of a novel model of care (“Stepping Up”) with usual primary c...
Objective To compare the effectiveness of a novel model of care (“Stepping Up”) with usu...
Objective To compare the effectiveness of a novel model of care ("Stepping Up") with usual primary c...
AIMS: To evaluate basal and prandial insulin initiation and titration in people with type 2 diabetes...
BACKGROUND: Type 2 diabetes (T2D) brings significant human and healthcare costs. Its progressive nat...
BACKGROUND: Type 2 diabetes (T2D) brings significant human and healthcare costs. Its progressive nat...
Aims: To evaluate basal and prandial insulin initiation and titration in people with type 2 diabetes...
BACKGROUND: Insulin initiation and titration in primary care is necessary to respond to the growing ...
BackgroundType 2 diabetes (T2D) brings significant human and healthcare costs. Its progressive natur...
Purpose of study: To evaluate the 3-year impact of initiating basal insulin on glycaemic control (H...
Type 2 diabetes (T2D) brings significant human and healthcare costs. Its progressive nature means ac...
Objective To evaluate the effects of insulin 30/70 twice daily or bedtime isophane (NPH) insulin plu...
Background. Most people with type 2 diabetes (T2D) have glycaemic levels outside of target. Insulin ...
Objective: To compare the effectiveness of a novel model of care (“Stepping Up”) with usual primary ...
Objective To compare the effectiveness of a novel model of care (“Stepping Up”) with usual primary c...
Objective To compare the effectiveness of a novel model of care (“Stepping Up”) with usual primary c...
Objective To compare the effectiveness of a novel model of care (“Stepping Up”) with usu...
Objective To compare the effectiveness of a novel model of care ("Stepping Up") with usual primary c...
AIMS: To evaluate basal and prandial insulin initiation and titration in people with type 2 diabetes...
BACKGROUND: Type 2 diabetes (T2D) brings significant human and healthcare costs. Its progressive nat...
BACKGROUND: Type 2 diabetes (T2D) brings significant human and healthcare costs. Its progressive nat...
Aims: To evaluate basal and prandial insulin initiation and titration in people with type 2 diabetes...
BACKGROUND: Insulin initiation and titration in primary care is necessary to respond to the growing ...
BackgroundType 2 diabetes (T2D) brings significant human and healthcare costs. Its progressive natur...
Purpose of study: To evaluate the 3-year impact of initiating basal insulin on glycaemic control (H...
Type 2 diabetes (T2D) brings significant human and healthcare costs. Its progressive nature means ac...
Objective To evaluate the effects of insulin 30/70 twice daily or bedtime isophane (NPH) insulin plu...
Background. Most people with type 2 diabetes (T2D) have glycaemic levels outside of target. Insulin ...